NMN and Cognitive Research

What this page covers, and its honest conclusion up front

This page evaluates human evidence specifically on cognition: memory, executive function, neuropsychological test performance, subjective cognitive complaints, and other neurological outcomes. The honest, direct answer is: human evidence on NMN and cognition is currently insufficient. Only one trial reviewed for this hub directly tested cognitive function in humans, and it found no significant effect. This page states that plainly rather than filling the gap with animal research and implying a human benefit.

The one human trial that tested cognition

A 12-week trial in 20 healthy men aged 65 and older included cognitive-function testing alongside its primary measures of blood NAD+ and muscle function.[1] Blood NAD+ increased significantly, as reported throughout this hub — but cognitive function was directly assessed using two validated instruments, the Mini-Mental State Examination-Japanese (MMSE-J) and the Japanese version of the Montreal Cognitive Assessment (MOCA-J), and the trial found no observable effect on overall cognitive function on either instrument.[1] This is a small trial (n=20), in a narrow population (healthy older men), so it should be read as one negative data point in a small sample using standard screening instruments rather than a comprehensive neuropsychological battery — not as definitive proof that NMN has no cognitive effect in any population. It is, however, the only direct human cognitive test identified in this hub's trial review, and its result was null on both instruments used.

What no human trial has tested

No human NMN trial identified for this hub has used a comprehensive neuropsychological test battery, has measured memory or executive function as a primary endpoint, has assessed subjective cognitive complaints systematically, or has studied any diagnosed neurological or cognitive condition (such as mild cognitive impairment or dementia). This is a genuine, large evidence gap — not a body of negative findings, simply an absence of adequately designed human research on this specific question.

Preclinical evidence exists — and is clearly separate

A peer-reviewed laboratory study in aged mice found that NMN supplementation rescued cerebromicrovascular endothelial function and neurovascular coupling responses, and was associated with improvements in spatial working memory and gait coordination in the animals.[2] This preclinical research is real, peer-reviewed, and is part of why cognition is an area of ongoing interest for NMN research. It is explicitly labeled PRECLINICAL here because it is: findings in mouse brain vasculature and behavior are not evidence of an effect in the human brain, and no study has bridged that specific gap for NMN and cognition in humans as of this review.

Why this page doesn't manufacture a stronger conclusion

The architecture of this hub calls for a page on this topic, but a scientifically honest page on a topic with minimal direct evidence should say so, rather than substitute mechanistic plausibility or animal data for a missing human answer. Readers interested in cognitive effects of NMN should understand clearly: this is one of the least-studied outcomes in the human NMN literature, the single direct test available — using two validated screening instruments — found no effect, and no claim of a cognitive benefit is supported by current human evidence.

Related reading

For the complete human trial record, see NMN Human Clinical Trials. For NAD+'s role in cellular stress and mitochondrial biology relevant to neurons, see NAD+, Mitochondria, and Cellular Energy and NAD+ and Sirtuins.